HUE047684T2 - Új szubsztituált cianoindolin származékok mint NIK inhibitorok - Google Patents
Új szubsztituált cianoindolin származékok mint NIK inhibitorokInfo
- Publication number
- HUE047684T2 HUE047684T2 HUE17701110A HUE17701110A HUE047684T2 HU E047684 T2 HUE047684 T2 HU E047684T2 HU E17701110 A HUE17701110 A HU E17701110A HU E17701110 A HUE17701110 A HU E17701110A HU E047684 T2 HUE047684 T2 HU E047684T2
- Authority
- HU
- Hungary
- Prior art keywords
- new substituted
- nik inhibitors
- cyanoindoline
- derivatives
- cyanoindoline derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/535—Organo-phosphoranes
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16152416 | 2016-01-22 | ||
| EP16159651 | 2016-03-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE047684T2 true HUE047684T2 (hu) | 2020-05-28 |
Family
ID=57868252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE17701110A HUE047684T2 (hu) | 2016-01-22 | 2017-01-20 | Új szubsztituált cianoindolin származékok mint NIK inhibitorok |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US11180487B2 (hu) |
| EP (1) | EP3405196B1 (hu) |
| JP (1) | JP6910359B2 (hu) |
| KR (1) | KR20180100441A (hu) |
| CN (1) | CN108697710B (hu) |
| AU (1) | AU2017209935B2 (hu) |
| BR (1) | BR112018014675B1 (hu) |
| CA (1) | CA3011880A1 (hu) |
| DK (1) | DK3405196T3 (hu) |
| ES (1) | ES2775449T3 (hu) |
| HR (1) | HRP20200133T1 (hu) |
| HU (1) | HUE047684T2 (hu) |
| IL (1) | IL260500B (hu) |
| LT (1) | LT3405196T (hu) |
| MX (1) | MX2018008974A (hu) |
| PH (1) | PH12018501567A1 (hu) |
| SI (1) | SI3405196T1 (hu) |
| TW (1) | TWI739783B (hu) |
| WO (1) | WO2017125530A1 (hu) |
| ZA (1) | ZA201804688B (hu) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3405196T3 (en) | 2016-01-22 | 2020-03-09 | Janssen Pharmaceutica Nv | Nye substituerede cyanoindolinderivater som nik-inhibitorer |
| KR20180098679A (ko) | 2016-01-22 | 2018-09-04 | 잔센파마슈티카엔.브이. | Nik 억제제로서의 신규 6원 헤테로방향족 치환된 시아노인돌린 유도체 |
| EP3478673B1 (en) | 2016-06-30 | 2020-09-16 | Janssen Pharmaceutica NV | Cyanoindoline derivatives as nik inhibitors |
| EP3478675B1 (en) | 2016-06-30 | 2020-04-22 | Janssen Pharmaceutica NV | Heteroaromatic derivatives as nik inhibitors |
| JP6740452B2 (ja) * | 2016-07-26 | 2020-08-12 | 深▲セン▼市塔吉瑞生物医▲薬▼有限公司Ｓｈｅｎｚｈｅｎ ＴａｒｇｅｔＲｘ，Ｉｎｃ． | プロテインチロシンキナーゼの活性を阻害するためのアミノピリミジン系化合物 |
| NZ763197A (en) | 2017-09-30 | 2024-03-22 | Haihe Biopharma Co Ltd | Compound having erk kinase inhibitory activity and use thereof |
| TW202045008A (zh) | 2019-02-01 | 2020-12-16 | 印度商皮埃企業有限公司 | 4-取代的異噁唑/異噁唑啉(雜)芳基脒化合物、及其製備與用途 |
| EP3950678A4 (en) * | 2019-04-02 | 2023-04-26 | Hinova Pharmaceuticals Inc. | AROMATIC AMINE COMPOUND AND ITS USE IN THE PREPARATION OF DUAL AR AND BRD4 INHIBITORS AND REGULATORS |
| AU2020282005A1 (en) | 2019-05-31 | 2021-12-23 | Janssen Pharmaceutica Nv | Small molecule inhibitors of NF-kB inducing kinase |
| CN117858727A (zh) | 2021-08-23 | 2024-04-09 | 国立大学法人大阪大学 | 抑制成熟肝细胞转分化的组合物 |
| WO2024059200A1 (en) | 2022-09-14 | 2024-03-21 | Halia Therapeutics, Inc. | Nek7 inhibitors |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003511378A (ja) | 1999-10-07 | 2003-03-25 | アムジエン・インコーポレーテツド | トリアジン系キナーゼ阻害薬 |
| CN1429222A (zh) | 2000-02-17 | 2003-07-09 | 安姆根有限公司 | 激酶抑制剂 |
| ATE311366T1 (de) | 2000-02-29 | 2005-12-15 | Millennium Pharm Inc | Benzamide und ähnliche inhibitoren vom faktor xa |
| EP1373257B9 (en) * | 2001-03-29 | 2008-10-15 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| US7087614B2 (en) | 2001-06-19 | 2006-08-08 | Bristol-Myers Squibb Co. | Pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| WO2003030909A1 (en) * | 2001-09-25 | 2003-04-17 | Bayer Pharmaceuticals Corporation | 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer |
| WO2009158011A1 (en) * | 2008-06-26 | 2009-12-30 | Amgen Inc. | Alkynyl alcohols as kinase inhibitors |
| CN102083800A (zh) | 2008-06-27 | 2011-06-01 | 阿维拉制药公司 | 杂芳基化合物和其用途 |
| US20110183975A1 (en) * | 2008-10-07 | 2011-07-28 | Yasuhiro Goto | Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activity |
| ES2608670T3 (es) | 2009-08-17 | 2017-04-12 | Memorial Sloan-Kettering Cancer Center | Derivados de 2-(pirimidin-5-il)-tiopirimidina como moduladores de Hsp70 y Hsc70 para el tratamiento de trastornos proliferativos |
| WO2011153553A2 (en) | 2010-06-04 | 2011-12-08 | The Regents Of The University Of California | Methods and compositions for kinase inhibition |
| MY165584A (en) | 2010-07-29 | 2018-04-05 | Rigel Pharmaceuticals Inc | Ampk-activating heterocyclic compounds and methods for using the same |
| CA2832919A1 (en) | 2011-04-12 | 2012-10-18 | Ryan C. Holcomb | Compounds, compositions, and therapeutic uses thereof |
| TWI663166B (zh) | 2013-04-24 | 2019-06-21 | 健生藥品公司 | 新化合物 |
| EA034866B1 (ru) | 2013-08-30 | 2020-03-31 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Замещенные пиримидиновые ингибиторы bmi-1 |
| TWI627173B (zh) | 2013-09-26 | 2018-06-21 | 比利時商健生藥品公司 | 作為ＮＩＫ抑制劑的新穎３－（１Ｈ－吡唑－４－基）－１Ｈ－吡咯并［２，３－ｃ］吡啶衍生物 |
| TWI704146B (zh) | 2013-09-26 | 2020-09-11 | 比利時商健生藥品公司 | 用作ＮＩＫ抑制劑之新的1-(４-嘧啶基)-１Ｈ-吡唑並[３,２-ｃ]吡啶衍生物 |
| SG11201608242XA (en) | 2014-04-04 | 2016-10-28 | Syros Pharmaceuticals Inc | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
| SG11201608342VA (en) | 2014-05-22 | 2016-11-29 | Univ Sydney | Omega-3 analogues |
| WO2016022645A1 (en) | 2014-08-06 | 2016-02-11 | Merck Sharp & Dohme Corp. | Heterocyclic cgrp receptor antagonists |
| MX2017003930A (es) | 2014-09-26 | 2017-06-30 | Gilead Sciences Inc | Derivados de aminotriazina utiles como compuestos inhibidores de la cinasa de union a tank. |
| CN106928216A (zh) | 2015-12-31 | 2017-07-07 | 中国科学院上海药物研究所 | 具有erk激酶抑制活性的化合物、其制备方法和用途 |
| KR20180098679A (ko) | 2016-01-22 | 2018-09-04 | 잔센파마슈티카엔.브이. | Nik 억제제로서의 신규 6원 헤테로방향족 치환된 시아노인돌린 유도체 |
| DK3405196T3 (en) | 2016-01-22 | 2020-03-09 | Janssen Pharmaceutica Nv | Nye substituerede cyanoindolinderivater som nik-inhibitorer |
| MX2018011105A (es) | 2016-03-16 | 2018-11-22 | Kura Oncology Inc | Inhibidores sustituidos de menina-mll y metodos de uso. |
| EP3478673B1 (en) | 2016-06-30 | 2020-09-16 | Janssen Pharmaceutica NV | Cyanoindoline derivatives as nik inhibitors |
| EP3478675B1 (en) | 2016-06-30 | 2020-04-22 | Janssen Pharmaceutica NV | Heteroaromatic derivatives as nik inhibitors |
-
2017
- 2017-01-20 DK DK17701110.3T patent/DK3405196T3/da active
- 2017-01-20 CN CN201780007786.1A patent/CN108697710B/zh active Active
- 2017-01-20 HU HUE17701110A patent/HUE047684T2/hu unknown
- 2017-01-20 WO PCT/EP2017/051150 patent/WO2017125530A1/en active Application Filing
- 2017-01-20 SI SI201730183T patent/SI3405196T1/sl unknown
- 2017-01-20 TW TW105143703A patent/TWI739783B/zh active
- 2017-01-20 BR BR112018014675-7A patent/BR112018014675B1/pt active IP Right Grant
- 2017-01-20 EP EP17701110.3A patent/EP3405196B1/en active Active
- 2017-01-20 KR KR1020187024257A patent/KR20180100441A/ko not_active Application Discontinuation
- 2017-01-20 JP JP2018535876A patent/JP6910359B2/ja active Active
- 2017-01-20 US US16/071,192 patent/US11180487B2/en active Active
- 2017-01-20 MX MX2018008974A patent/MX2018008974A/es unknown
- 2017-01-20 AU AU2017209935A patent/AU2017209935B2/en active Active
- 2017-01-20 CA CA3011880A patent/CA3011880A1/en active Pending
- 2017-01-20 ES ES17701110T patent/ES2775449T3/es active Active
- 2017-01-20 LT LTEP17701110.3T patent/LT3405196T/lt unknown
-
2018
- 2018-07-09 IL IL260500A patent/IL260500B/en active IP Right Grant
- 2018-07-13 ZA ZA2018/04688A patent/ZA201804688B/en unknown
- 2018-07-23 PH PH12018501567A patent/PH12018501567A1/en unknown
-
2020
- 2020-01-29 HR HRP20200133TT patent/HRP20200133T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LT3405196T (lt) | 2020-02-25 |
| MX2018008974A (es) | 2018-11-09 |
| BR112018014675A2 (pt) | 2018-12-11 |
| IL260500B (en) | 2021-01-31 |
| US20210087182A1 (en) | 2021-03-25 |
| CN108697710A (zh) | 2018-10-23 |
| KR20180100441A (ko) | 2018-09-10 |
| AU2017209935A1 (en) | 2018-08-09 |
| BR112018014675B1 (pt) | 2023-12-19 |
| ES2775449T3 (es) | 2020-07-27 |
| SI3405196T1 (sl) | 2020-03-31 |
| CN108697710B (zh) | 2022-02-18 |
| EP3405196B1 (en) | 2019-12-04 |
| DK3405196T3 (en) | 2020-03-09 |
| PH12018501567A1 (en) | 2019-01-28 |
| ZA201804688B (en) | 2022-03-30 |
| TW201728577A (zh) | 2017-08-16 |
| JP6910359B2 (ja) | 2021-07-28 |
| AU2017209935B2 (en) | 2021-04-01 |
| EP3405196A1 (en) | 2018-11-28 |
| US11180487B2 (en) | 2021-11-23 |
| WO2017125530A1 (en) | 2017-07-27 |
| JP2019504067A (ja) | 2019-02-14 |
| CA3011880A1 (en) | 2017-07-27 |
| HRP20200133T1 (hr) | 2020-05-15 |
| TWI739783B (zh) | 2021-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2400003I1 (hu) | Kináz inhibitorként alkalmas vegyületek | |
| HK1255045A1 (zh) | 取代的氧代吡啶衍生物 | |
| IL289474A (en) | Substituted thiazolo-pyridine compounds as malt1 inhibitors | |
| HRP20200133T1 (hr) | Novi supstituirani derivati cijanoindolina kao inhibitori nik | |
| HUE059324T2 (hu) | Heterociklusos vegyületek, mint PI3K-gamma inhibitorok | |
| IL255750A (en) | Heterocyclic compounds as kinase inhibitors | |
| IL251777A0 (en) | New pyrazole histories as nik inhibitors | |
| IL251780A0 (en) | New compounds as nik inhibitors | |
| IL251779A0 (en) | Novel thianopyrimidine histories as nik inhibitors | |
| IL251778B (en) | Novel pyrazolopyrimidine histories as nik inhibitors | |
| IL271808A (en) | Novel mutated azaindoline derivatives as NIK inhibitors | |
| HK1252767A1 (zh) | 作為eaat3抑制劑的吡唑-吡啶衍生物 | |
| IL254890B (en) | The tercyclic compound | |
| RS61991B1 (sr) | Derivati pirazolilaminobenzimidazola kao jak inhibitori | |
| IL264465B (en) | Substituted thiazolo-pyridine compounds as malt1 inhibitors | |
| GB201522245D0 (en) | Compounds useful as kinase inhibitors |